Scimago Journal & Country Rank
menu
| Title | Type | SJR |  H index |
Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Current Neuropharmacology | journal | 1.722 Q1 | 103 | 145 | 278 | 19000 | 2463 | 258 | 7.25 | 131.03 | 39.67 |  |
| 2 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.629 Q2 | 52 | 42 | 88 | 3536 | 322 | 85 | 2.84 | 84.19 | 44.10 | |
| 3 | Current Reviews in Clinical and Experimental Pharmacology | journal | 0.536 Q2 | 49 | 44 | 85 | 1993 | 271 | 79 | 2.49 | 45.30 | 39.52 | |
| 4 | Current Drug Safety | journal | 0.333 Q3 | 41 | 36 | 121 | 2378 | 232 | 118 | 1.27 | 66.06 | 40.21 | |
| 5 | Recent Advances in Anti-Infective Drug Discovery | journal | 0.301 Q3 | 38 | 21 | 44 | 974 | 87 | 38 | 1.40 | 46.38 | 40.96 | |
| 6 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 14 | 47 | 677 | 296 | 45 | 6.27 | 48.36 | 48.98 | | |
| 7 | Drug Metabolism Letters | journal | 0.357 Q3 | 31 | 24 | 34 | 1151 | 66 | 29 | 1.86 | 47.96 | 25.84 | |
| 8 | Current Signal Transduction Therapy | journal | 0.151 Q4 | 22 | 33 | 72 | 1639 | 58 | 65 | 0.67 | 49.67 | 40.35 | |
| 9 | Current Drug Therapy | journal | 0.175 Q4 | 20 | 40 | 88 | 1989 | 77 | 86 | 0.86 | 49.73 | 39.74 | |
| 10 | Anti-Obesity Drug Discovery and Development | book series | 1 | 5 | 2 | 1128 | 1 | 0 | 0.50 | 225.60 | 0.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data